Generate a tailored SOP for Dr. Kiran Turaga. Improve your application with a focused, well-structured draft.
Kiran Turaga, MD, MPH, is the Division Chief of Surgical Oncology and the Assistant Medical Director for the Clinical Trials Office at Yale Cancer Center. He previously served as Vice Chief of the Section of General Surgery and Surgical Oncology at the University of Chicago, where he directed the Surgical Gastrointestinal Cancer Program and Regional Therapeutics. As a thought leader in managing oligometastatic cancer, Dr. Turaga specializes in regional perfusion and hyperthermic intraperitoneal chemotherapy (HIPEC), techniques that deliver heated chemotherapy directly to abdominal organs to treat residual cancer post-surgery. His research emphasizes the development of novel diagnostics and therapeutics for oligometastatic cancer and he is currently involved in clinical trials exploring the intersection of immunotherapy and liquid biopsy for surgical cancer management. Passionate about improving patient care through big data systems, Dr. Turaga aims to provide optimal and cost-effective solutions for complex cancer treatments.
Administered via the Graduate School of Arts and Sciences (GSAS). GRE General is optional for PhD.